Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Recursion Pharmaceuticals, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Biological Products, (No Diagnostic Substances)
Prev close 3.24 · gapped above the open, then crossed back over prior close. High/low 3.40 at 7:45 am ET, 3.23 at 10:45 am ET.
345 institutional managers report a position in Recursion Pharmaceuticals, Inc. worth $1.4B between them, filed on form 13F for the quarter ending 2026-06-30. 19 of them hold 80% of it, the largest being BlackRock, Inc. at 13.55%.
320 more managers in the register
19 managers hold 80% of the $1.4B institutional base. The other 326 hold the rest.
Positions as filed with the SEC for the quarter ended Jun 30. A 13F is due 45 days after the quarter closes, so this register is 78 days old and does not move with the price above it.
via ARK Investment Management LLC, Baillie Gifford & Co, Softbank Group Corp +5 more · 11.14% of RXRX, 7.32% of TEM
via ARK Investment Management LLC, Softbank Group Corp, Nikko Asset Management Americas, Inc. +2 more · 11.14% of RXRX, 15.50% of PACB
via ARK Investment Management LLC, Nikko Asset Management Americas, Inc., Sumitomo Mitsui Trust Holdings, Inc. +3 more · 11.14% of RXRX, 12.16% of CRSP
via ARK Investment Management LLC, Sumitomo Mitsui Trust Holdings, Inc., Nikko Asset Management Americas, Inc. +3 more · 11.14% of RXRX, 11.60% of ARCT
via ARK Investment Management LLC, Nikko Asset Management Americas, Inc., Sumitomo Mitsui Trust Holdings, Inc. +2 more · 11.14% of RXRX, 15.32% of BLSH
via ARK Investment Management LLC, Sumitomo Mitsui Trust Holdings, Inc., Nikko Asset Management Americas, Inc. +1 more · 11.14% of RXRX, 13.31% of QSI
Managers holding a meaningful stake in RXRX also hold this much of the other company’s institutional base. Managers who hold most of the companies we cover are excluded, because their overlap says nothing about this one in particular. This is how the two are held, not evidence that one moves the other.
RXRX (Recursion Pharmaceuticals, Inc.) has 12 disclosed suppliers and 5 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
Largest move on the map today: RLYB −1.28%, in healthcare.